Condition
Pouches, Ileoanal
Total Trials
5
Recruiting
2
Active
2
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
40%
2 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (1)
P 1 (1)
P 4 (2)
Trial Status
Recruiting2
Not Yet Recruiting1
Withdrawn1
Completed1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07756359Phase 4Not Yet Recruiting
Tirzepatide for Ileal Pouch-anal Anastomosis (IPAA) and Chronic High Bowel Frequency (I8F-NS-X008)
NCT07726771Not ApplicableRecruiting
Evaluation of the Ileo-anal Pouch in FAP (ENDOPOL)
NCT04073472Phase 1Withdrawn
Mesenchymal Stem Cells for the Treatment of Pouch Fistulas in Crohn's
NCT06864403Phase 4Recruiting
Mirikizumab in the Treatment of Chronic Inflammatory Conditions of the Pouch
NCT04864587CompletedPrimary
Artificial Intelligence in Image Recognition of Pouchoscopies in Patients With Restorative Proctocolectomy
Showing all 5 trials